Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in drug major

Sun Pharma, Cassiopea Spa Ink License & Supply Agreements For Acne Treatment Drug Winlevi

The USFDA approved Winlevi (clascoterone cream 1 per cent) in August 2020, for the topical treatment of acne vulgaris in patients 12 years and older.

Read More

Cipla Gets USFDA Nod For Inhalation Product

Brovana is used in maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Read More

Sun Pharma Settles Patent Litigation With Celgene Corporation For Cancer Drug Revlimid

Shares of Sun Pharma were trading 0.19 per cent lower at Rs 669.95 apiece on BSE.

Read More

Lupin Launches Digital Asthma Educator Platform

The new platform is the latest initiative under Lupin's long running umbrella programme, Joint Airways Initiative (JAI), for patients suffering from respiratory ailments.

Read More

Lupin To Enter Digital Healthcare Space In India

Shares of Lupin Ltd were trading 0.29 per cent lower at Rs 1,243.30 apiece on BSE.

Read More

Sun Pharma Acquires Rights To Trademarks Of 3 Diabetes Drug Brands In India From AstraZeneca

AstraZeneca India and Sun Pharma have discontinued their existing distribution services agreement signed in 2016, for distribution of Dapagliflozin.

Read More

Sun Pharma Q4 Net Profit Zooms Over Two-Fold To Rs 894.15 Cr

Shares of Sun Pharmaceutical Industries closed at Rs 699.75 per scrip on BSE, down 0.55 per cent from its previous close.

Read More

Sun Pharma Recalls 50,868 Bottles Of Diabetes Drug In US

The US-based arm of the drug firm is recalling the affected lot of 500 mg tablets (in 500 count bottles) due to 'presence of foreign substance identified as activated carbon', as per the latest Enforcement Report issued by the US health regulator.

Read More

Cipla Launches RT-PCR Test Kit 'Viragen' In India Partnership With Ubio Biotech

Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems

Read More

Natco Seeks CDSCO Approval For Phase-III Trial Of Molnupiravir For COVID-19 Treatment

Natco Pharma has applied to the Central Drugs Standard Control Organization (CDSCO) in India for approval of phase-III clinical trial of Molnupiravir capsules for the treatment of COVID-19 positive patients

Read More

Dr Reddy's Receives DCGI Approval For COVID-19 Vaccine Sputnik For Restricted Emergency Use

Dr Reddy's had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and distribute the vaccine in India.

Read More

Natco Pharma Board Okays Acquiring 1% In Canadian Arm

Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE.

Read More

Wall Street Shifts Bets To Big Pharma As COVID-19 Vaccine Race Progresses

Companies including Pfizer and Johnson & Johnson have said they each aim to produce as many as 1 billion doses by the end of 2021.

Read More